Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice

Chi Young Song, Khuzema Ghafoor, Hafiz U. Ghafoor, Nayaab S. Khan, Shyamala Thirunavukkarasu, Brett L. Jennings, Anne M. Estes, Sahar Zaidi, Dave Bridges, Patrick Tso, Frank J. Gonzalez, Kafait Malik

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cytochrome P450 (CYP) 1B1 contributes to vascular smooth muscle cell growth and hypertension in male mice. This study was conducted to determine the contribution of CYP1B1 to the development of atherosclerosis and hypertension and associated pathogenesis in 8-week-old male apolipoprotein E-deficient (ApoE-/-/Cyp1b1+/+), and ApoE- and CYP1B1-deficient (ApoE-/-/Cyp1b1-/-) mice fed a normal or atherogenic diet for 12 weeks. A separate group of ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet was injected every third day with the CYP1B1 inhibitor, 2,3′,4,5′-tetramethoxystilbene (300 μg/kg), or its vehicle, dimethyl sulfoxide (30 μL, IP); systolic blood pressure was measured by the tail cuff method. After 12 weeks, mice were euthanized, blood collected for lipid analysis, and aortas harvested for measuring lesions and remodeling, and for infiltration of inflammatory cells by histological and immunohistochemical analysis, respectively, and for reactive oxygen species production. Blood pressure, areas of lipids and collagen deposition, elastin breaks, infiltration of macrophages and T lymphocytes, reactive oxygen species generation in the aorta, and plasma lipid levels were increased in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet; these changes were minimized in mice given 2,3′,4,5′-tetramethoxystilbene, and in ApoE-/-/Cyp1b1-/- mice on an atherogenic diet; absorption/production of lipids remained unaltered in these mice. These data suggest that aortic lesions, hypertension, and associated pathogenesis in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet are most likely dependent on CYP1B1-generated oxidative stress and increased plasma lipid levels independent of blood pressure and absorption of lipids. CYP1B1 could serve as a novel target for developing drugs to treat atherosclerosis and hypertension caused by hypercholesterolemia.

Original languageEnglish (US)
Pages (from-to)206-213
Number of pages8
JournalHypertension
Volume67
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Apolipoproteins E
Cytochrome P-450 Enzyme System
Atherosclerosis
Atherogenic Diet
Hypertension
Lipids
Blood Pressure
Aorta
Reactive Oxygen Species
Elastin
Dimethyl Sulfoxide
Hypercholesterolemia
Vascular Smooth Muscle
Smooth Muscle Myocytes
Tail
Oxidative Stress
Collagen
Macrophages
T-Lymphocytes
Growth

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice. / Song, Chi Young; Ghafoor, Khuzema; Ghafoor, Hafiz U.; Khan, Nayaab S.; Thirunavukkarasu, Shyamala; Jennings, Brett L.; Estes, Anne M.; Zaidi, Sahar; Bridges, Dave; Tso, Patrick; Gonzalez, Frank J.; Malik, Kafait.

In: Hypertension, Vol. 67, No. 1, 01.01.2016, p. 206-213.

Research output: Contribution to journalArticle

Song, CY, Ghafoor, K, Ghafoor, HU, Khan, NS, Thirunavukkarasu, S, Jennings, BL, Estes, AM, Zaidi, S, Bridges, D, Tso, P, Gonzalez, FJ & Malik, K 2016, 'Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice', Hypertension, vol. 67, no. 1, pp. 206-213. https://doi.org/10.1161/HYPERTENSIONAHA.115.06427
Song, Chi Young ; Ghafoor, Khuzema ; Ghafoor, Hafiz U. ; Khan, Nayaab S. ; Thirunavukkarasu, Shyamala ; Jennings, Brett L. ; Estes, Anne M. ; Zaidi, Sahar ; Bridges, Dave ; Tso, Patrick ; Gonzalez, Frank J. ; Malik, Kafait. / Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice. In: Hypertension. 2016 ; Vol. 67, No. 1. pp. 206-213.
@article{f9fa87f7cae3468b93ae247225497586,
title = "Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice",
abstract = "Cytochrome P450 (CYP) 1B1 contributes to vascular smooth muscle cell growth and hypertension in male mice. This study was conducted to determine the contribution of CYP1B1 to the development of atherosclerosis and hypertension and associated pathogenesis in 8-week-old male apolipoprotein E-deficient (ApoE-/-/Cyp1b1+/+), and ApoE- and CYP1B1-deficient (ApoE-/-/Cyp1b1-/-) mice fed a normal or atherogenic diet for 12 weeks. A separate group of ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet was injected every third day with the CYP1B1 inhibitor, 2,3′,4,5′-tetramethoxystilbene (300 μg/kg), or its vehicle, dimethyl sulfoxide (30 μL, IP); systolic blood pressure was measured by the tail cuff method. After 12 weeks, mice were euthanized, blood collected for lipid analysis, and aortas harvested for measuring lesions and remodeling, and for infiltration of inflammatory cells by histological and immunohistochemical analysis, respectively, and for reactive oxygen species production. Blood pressure, areas of lipids and collagen deposition, elastin breaks, infiltration of macrophages and T lymphocytes, reactive oxygen species generation in the aorta, and plasma lipid levels were increased in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet; these changes were minimized in mice given 2,3′,4,5′-tetramethoxystilbene, and in ApoE-/-/Cyp1b1-/- mice on an atherogenic diet; absorption/production of lipids remained unaltered in these mice. These data suggest that aortic lesions, hypertension, and associated pathogenesis in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet are most likely dependent on CYP1B1-generated oxidative stress and increased plasma lipid levels independent of blood pressure and absorption of lipids. CYP1B1 could serve as a novel target for developing drugs to treat atherosclerosis and hypertension caused by hypercholesterolemia.",
author = "Song, {Chi Young} and Khuzema Ghafoor and Ghafoor, {Hafiz U.} and Khan, {Nayaab S.} and Shyamala Thirunavukkarasu and Jennings, {Brett L.} and Estes, {Anne M.} and Sahar Zaidi and Dave Bridges and Patrick Tso and Gonzalez, {Frank J.} and Kafait Malik",
year = "2016",
month = "1",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.115.06427",
language = "English (US)",
volume = "67",
pages = "206--213",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice

AU - Song, Chi Young

AU - Ghafoor, Khuzema

AU - Ghafoor, Hafiz U.

AU - Khan, Nayaab S.

AU - Thirunavukkarasu, Shyamala

AU - Jennings, Brett L.

AU - Estes, Anne M.

AU - Zaidi, Sahar

AU - Bridges, Dave

AU - Tso, Patrick

AU - Gonzalez, Frank J.

AU - Malik, Kafait

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Cytochrome P450 (CYP) 1B1 contributes to vascular smooth muscle cell growth and hypertension in male mice. This study was conducted to determine the contribution of CYP1B1 to the development of atherosclerosis and hypertension and associated pathogenesis in 8-week-old male apolipoprotein E-deficient (ApoE-/-/Cyp1b1+/+), and ApoE- and CYP1B1-deficient (ApoE-/-/Cyp1b1-/-) mice fed a normal or atherogenic diet for 12 weeks. A separate group of ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet was injected every third day with the CYP1B1 inhibitor, 2,3′,4,5′-tetramethoxystilbene (300 μg/kg), or its vehicle, dimethyl sulfoxide (30 μL, IP); systolic blood pressure was measured by the tail cuff method. After 12 weeks, mice were euthanized, blood collected for lipid analysis, and aortas harvested for measuring lesions and remodeling, and for infiltration of inflammatory cells by histological and immunohistochemical analysis, respectively, and for reactive oxygen species production. Blood pressure, areas of lipids and collagen deposition, elastin breaks, infiltration of macrophages and T lymphocytes, reactive oxygen species generation in the aorta, and plasma lipid levels were increased in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet; these changes were minimized in mice given 2,3′,4,5′-tetramethoxystilbene, and in ApoE-/-/Cyp1b1-/- mice on an atherogenic diet; absorption/production of lipids remained unaltered in these mice. These data suggest that aortic lesions, hypertension, and associated pathogenesis in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet are most likely dependent on CYP1B1-generated oxidative stress and increased plasma lipid levels independent of blood pressure and absorption of lipids. CYP1B1 could serve as a novel target for developing drugs to treat atherosclerosis and hypertension caused by hypercholesterolemia.

AB - Cytochrome P450 (CYP) 1B1 contributes to vascular smooth muscle cell growth and hypertension in male mice. This study was conducted to determine the contribution of CYP1B1 to the development of atherosclerosis and hypertension and associated pathogenesis in 8-week-old male apolipoprotein E-deficient (ApoE-/-/Cyp1b1+/+), and ApoE- and CYP1B1-deficient (ApoE-/-/Cyp1b1-/-) mice fed a normal or atherogenic diet for 12 weeks. A separate group of ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet was injected every third day with the CYP1B1 inhibitor, 2,3′,4,5′-tetramethoxystilbene (300 μg/kg), or its vehicle, dimethyl sulfoxide (30 μL, IP); systolic blood pressure was measured by the tail cuff method. After 12 weeks, mice were euthanized, blood collected for lipid analysis, and aortas harvested for measuring lesions and remodeling, and for infiltration of inflammatory cells by histological and immunohistochemical analysis, respectively, and for reactive oxygen species production. Blood pressure, areas of lipids and collagen deposition, elastin breaks, infiltration of macrophages and T lymphocytes, reactive oxygen species generation in the aorta, and plasma lipid levels were increased in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet; these changes were minimized in mice given 2,3′,4,5′-tetramethoxystilbene, and in ApoE-/-/Cyp1b1-/- mice on an atherogenic diet; absorption/production of lipids remained unaltered in these mice. These data suggest that aortic lesions, hypertension, and associated pathogenesis in ApoE-/-/Cyp1b1+/+ mice on an atherogenic diet are most likely dependent on CYP1B1-generated oxidative stress and increased plasma lipid levels independent of blood pressure and absorption of lipids. CYP1B1 could serve as a novel target for developing drugs to treat atherosclerosis and hypertension caused by hypercholesterolemia.

UR - http://www.scopus.com/inward/record.url?scp=84951570156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951570156&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.115.06427

DO - 10.1161/HYPERTENSIONAHA.115.06427

M3 - Article

VL - 67

SP - 206

EP - 213

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -